The company plans to unblind
the AIM2CERV clinical data generated to date and anticipates submitting these data for publication.
In addition to a decline in core operating profit, the corresponding period of the previous year saw a reversal of expenses resulting from the decreased fair value of contingent consideration following the Company's decision to unblind
the global Phase 3 study of napabucasin for gastric and gastro-esophageal junction cancer patients, which is under development by Boston Biomedical, Inc.
The CEO of NWBio commented: "We are excited to see how the data are maturing, and we are grateful to our Scientific Advisory Board for their strong advice not to unblind
the trial too early.
precued choice RT push  sham controlled button right hand Mannarelli 79% 12 Crossover Precued choice RT push et al.
Each scan is annotated by up to 4 radiologists in a two-phase annotation process (blind and unblind
the received signature of the message-signature pair, the requester A first takes the blind signature S, the previously generated message digest m, the private key [n.sub.A], and the public key [PK.sub.B] of the signer to extract the blinded signature S' as expressed by (23).
I still remember when the statistician pressed the button to unblind
He concludes that "the two factors most likely to influence the behavior of French jurors were their extreme harshness towards property crimes and their relative indifference to violent crimes" ("Justice Unblind
Depending on the success of the company's efforts to pursue strategic options for continuing its clinical programs, the company may determine to conclude the study beyond December 31 and unblind
the study data at the assessments of the primary efficacy endpoint, i.e., 90 days post treatment of the last enrolled patient.
Enactment of speculative non-buddhist heuristics enables the Buddhist to unbind and unblind
from the coercive yet largely unconscious effects of the charism.
Based on the FDA guidance, the Company will now unblind
the trial results after the final follow-up safety visit instead of after the primary efficacy endpoint, as previously planned.